Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
1.
Am J Clin Dermatol ; 21(5): 669-680, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32468356

ABSTRACT

BACKGROUND: There has been a significant increase in the number and efficacy of therapies for advanced melanoma. Immunotherapies, such as anti-cytotoxic T-lymphocyte antigen-4 and programmed cell death-1 inhibitors, have improved the prognosis for patients with advanced melanoma. While spontaneous melanoma-associated vitiligo is a known phenomenon, the occurrence of melanoma-associated vitiligo following melanoma therapy is now recognized to associate with favorable outcomes. OBJECTIVE: The objective of this article is to provide a comprehensive literature review of melanoma-associated vitiligo and explore the insights these findings provide about the pathobiology of vitiligo and mechanisms underlying melanoma therapies. METHODS: PubMed and Science Direct databases were searched for studies pertaining to melanoma-associated vitiligo. The 36 studies reviewed included meta-analyses (n = 2), prospective cohort studies (n = 4), prospective observational studies (n = 3), retrospective studies (n = 12), case series (n = 2), and case reports (n = 13). RESULTS: The basic mechanisms underlying melanoma-associated vitiligo and vitiligo may be shared. Characterization of these mechanisms will identify new biomarkers and therapeutic targets for both melanoma and vitiligo. CONCLUSIONS: Co-opting the immune system to target tumor antigens highlights the potential overlap between anti-tumor immunity and autoimmunity. The development of vitiligo-like depigmentation in association with immunotherapy for melanoma may provide insights into both the immune response against melanoma as well as the pathogenesis of vitiligo.


Subject(s)
Immune Checkpoint Inhibitors/therapeutic use , Melanoma/drug therapy , Skin Neoplasms/drug therapy , Vitiligo/immunology , Antigens, Neoplasm/immunology , Antigens, Neoplasm/metabolism , CTLA-4 Antigen/antagonists & inhibitors , CTLA-4 Antigen/immunology , Diagnosis, Differential , Humans , Immune Checkpoint Inhibitors/pharmacology , Melanoma/complications , Melanoma/immunology , Prognosis , Programmed Cell Death 1 Receptor/antagonists & inhibitors , Programmed Cell Death 1 Receptor/immunology , Prospective Studies , Retrospective Studies , Skin Neoplasms/complications , Skin Neoplasms/immunology , Skin Pigmentation/drug effects , Skin Pigmentation/immunology , Treatment Outcome , Vitiligo/diagnosis , Vitiligo/epidemiology
2.
Int J Dermatol ; 59(11): 1341-1342, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32386084
3.
J Am Acad Dermatol ; 81(1): 163-172, 2019 Jul.
Article in English | MEDLINE | ID: mdl-30905792

ABSTRACT

BACKGROUND: Prescription medications are among the most common causes of sexual dysfunction, and patients are often hesitant to seek help when experiencing these symptoms. OBJECTIVE: In this review, we identify the available evidence of sexual adverse effects in men using systemic dermatologic medications and suggest screening protocols and actions that may improve a patient's symptoms where possible. METHODS: A systematic review was conducted of all articles in the PubMed database published from the time of inception to May 2018 to identify studies evaluating the use of systemic dermatologic medications in men with evidence of sexual adverse effects. Subsequently, a secondary in-depth literature review was performed for each individual medication. RESULTS: There were 5497 articles reviewed in the primary systematic review, and 59 articles covering 11 systemic dermatologic medications met inclusion criteria. We identified level 1 evidence for sexual adverse effects as a primary outcome in patients taking finasteride. LIMITATIONS: Many included studies were limited by sample size and methodology. CONCLUSION: The information in this review may serve as a reference of adverse effects when deciding on a therapeutic agent and a guide to help identify patients to screen for sexual dysfunction.


Subject(s)
Adrenal Cortex Hormones/adverse effects , Dermatologic Agents/adverse effects , Dermatologic Agents/therapeutic use , Finasteride/adverse effects , Itraconazole/adverse effects , Sexual Dysfunction, Physiological/chemically induced , Adrenal Cortex Hormones/therapeutic use , Adult , Age Factors , Cyclosporine/adverse effects , Cyclosporine/therapeutic use , Finasteride/therapeutic use , Humans , Itraconazole/therapeutic use , Male , Middle Aged , Prevalence , Prognosis , Risk Assessment , Sexual Dysfunction, Physiological/epidemiology , Sexual Dysfunction, Physiological/physiopathology
4.
Clin Drug Investig ; 39(2): 197-203, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30471069

ABSTRACT

BACKGROUND: Organ transplantation is a significant risk factor for the development of skin cancer. The impact of skin type, immunosuppressive regimens, and photosensitizing agents requires further study. OBJECTIVE: The objective of this study was to compare skin cancer development between Caucasian and non-Caucasian transplant recipients at the University of Southern California. METHODS: We performed a retrospective chart review of lung and liver transplantations to determine the incidence of post-transplant skin cancer. Participants included patients who underwent lung or liver transplantation between 2005 and 2013 at our institution. Patients included in the study were limited to those who survived through the study observation period. RESULTS: We analyzed 475 patients who underwent transplantation, including 370 liver transplant recipients and 105 lung transplant recipients. Among these, 46.3% identified as Caucasian, while 53.7% were non-Caucasian. Over a mean follow-up of 7.9 years, 11.8% of Caucasian patients developed at least one skin cancer, compared with 2.7% of non-Caucasians (p < 0.001). However, irrespective of race, skin cancer development was significantly greater in lung compared with liver transplant recipients (20.0% vs. 3.2%, p < 0.001). The standard immunosuppressive and prophylactic regimens were mycophenolate mofetil and tacrolimus based for both transplants. Mycophenolate mofetil was maintained throughout the course in lung transplant patients, whereas this agent was reduced and terminated when possible in liver transplant recipients. In addition, during the years examined, voriconazole, a known photosensitizing agent, was used in lung transplant recipients to prevent aspergillosis. CONCLUSIONS: Fair skin type increases post-transplant skin cancer development, irrespective of the immunosuppressive regimen. A higher risk of skin cancer is associated with different regimens; in particular photosensitizing agents may increase risk in transplant recipients.


Subject(s)
Liver Transplantation/adverse effects , Lung Transplantation/adverse effects , Skin Neoplasms/epidemiology , Adult , Aged , Female , Humans , Incidence , Male , Middle Aged , Mycophenolic Acid/therapeutic use , Retrospective Studies , Tacrolimus/therapeutic use , Transplant Recipients
5.
Dermatol Surg ; 43 Suppl 1: S19-S24, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27399940

ABSTRACT

BACKGROUND: Laser therapy is a continuously evolving treatment option for scars, and the underlying therapeutic mechanisms continue to be elucidated. OBJECTIVE: To comprehensively review the literature to summarize the role of elastin in the formation scars, as well as treatment via therapeutic lasers. METHODS: Review of the PubMED/MEDLINE database for available studies pertaining to the role of elastic fibers in scar formation and after laser-based therapy. RESULTS: The loss and disorganization of elastic fiber components plays a role in the development of atrophic, hypertrophic, and keloid scars. While the majority of histologic studies focus on the underlying changes in collagen, neoelastogenesis and reorganization of elastic fibers have also been demonstrated in studies using ablative, nonablative, and fractional laser devices for the treatment of scars. CONCLUSION: Production of novel elastin and normalization of elastic fiber organization occur after a variety of resurfacing procedures to treat scarring. As the treatment modalities to manage scars continue to evolve, further characterization of the role of elastin in the skin and in scar formation is merited.


Subject(s)
Cicatrix/physiopathology , Cicatrix/therapy , Elastic Tissue/physiopathology , Elastin/physiology , Humans , Laser Therapy
6.
Am J Clin Dermatol ; 18(1): 87-96, 2017 Feb.
Article in English | MEDLINE | ID: mdl-28004257

ABSTRACT

The proportion of men receiving non-surgical cosmetic procedures has risen substantially in recent years. Various physiologic, anatomic, and motivational considerations differentiate the treatments for male and female patients. Nevertheless, research regarding approaches to the male cosmetic patient is scarce. We sought to provide an overview and sex-specific discussion of the most popular cosmetic dermatologic procedures pursued by men by conducting a comprehensive literature review pertaining to non-surgical cosmetic procedures in male patients. The most common and rapidly expanding non-surgical interventions in men include botulinum toxin, filler injection, chemical peels, microdermabrasion, laser resurfacing, laser hair removal, hair transplantation, and minimally invasive techniques for adipose tissue reduction. Important sex-specific factors associated with each of these procedures should be considered to best serve the male cosmetic patient.


Subject(s)
Cosmetic Techniques , Dermatologic Surgical Procedures/methods , Dermatology/methods , Female , Humans , Male , Sex Factors , Skin Aging
7.
Am J Dermatopathol ; 38(12): e163-e166, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27861183

ABSTRACT

Cutaneous discoloration secondary to dermal deposition of titanium dioxide (TiO2) particles is recognized but seldom reported in the literature. In this report, the authors describe the case of a 61-year-old gentleman, with a long history of alopecia areata, who presented with numerous, discrete dark blue macules on the scalp. Scanning electron microscopy with energy dispersive x-ray spectroscopy analysis ultimately identified the macules as deposits of TiO2. The patient had a history of intralesional triamcinolone injections for management of alopecia areata. A sample of generic 0.1% triamcinolone acetonide paste was analyzed and found to contain many TiO2 particles analogous to those seen in the patient's biopsy sample. To the authors' knowledge, this is the first reported case of TiO2 deposition in the dermis likely resulting from topical combined with intralesional triamcinolone injection.


Subject(s)
Alopecia Areata/drug therapy , Glucocorticoids/administration & dosage , Glucocorticoids/chemistry , Scalp/chemistry , Skin/chemistry , Titanium/analysis , Triamcinolone Acetonide/administration & dosage , Triamcinolone Acetonide/chemistry , Administration, Cutaneous , Biopsy , Drug Compounding , Humans , Injections, Intralesional , Microscopy, Electron, Scanning , Middle Aged , Scalp/ultrastructure , Skin/ultrastructure , Spectrometry, X-Ray Emission
8.
J Cutan Pathol ; 43(11): 1041-1044, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27433975

ABSTRACT

Lymphomatoid papulosis (LyP) is classified as a CD30+ primary cutaneous lymphoproliferative disease. The phenotypic variability along the spectrum of CD30+ lymphoproliferative diseases is highlighted by the distinct histologic subtypes of LyP types A, B, C, and the more recently described types D, E, and F. We report the case of an elderly woman with a clinical presentation and histopathologic findings consistent with LyP, whose atypical CD30+ infiltrate uniquely demonstrated a spindle-cell morphology. To our knowledge, this is the first reported case of LyP characterized by CD30+ spindle-shaped cells, and may represent a new and distinct histologic variant of LyP.


Subject(s)
Ki-1 Antigen/metabolism , Lymphomatoid Papulosis/diagnosis , Skin Neoplasms/diagnosis , Aged, 80 and over , Female , Humans , Lymphomatoid Papulosis/immunology , Skin Neoplasms/immunology
9.
J Am Board Fam Med ; 29(6): 808-812, 2016 11 12.
Article in English | MEDLINE | ID: mdl-28076265

ABSTRACT

BACKGROUND: Lymphangitic streaking, characterized by linear erythema on the skin, is most commonly observed in the setting of bacterial infection. However, a number of nonbacterial causes can result in lymphangitic streaking. We sought to elucidate the nonbacterial causes of lymphangitic streaking that may mimic bacterial infection to broaden clinicians' differential diagnosis for patients presenting with lymphangitic streaking. METHODS: We performed a review of the literature, including all available reports pertaining to nonbacterial causes of lymphangitic streaking. RESULTS: Various nonbacterial causes can result in lymphangitic streaking, including viral and fungal infections, insect or spider bites, and iatrogenic etiologies. CONCLUSION: Awareness of potential nonbacterial causes of superficial lymphangitis is important to avoid misdiagnosis and delay the administration of appropriate care.


Subject(s)
Bacterial Infections/diagnosis , Bites and Stings/diagnosis , Lymphangitis/diagnosis , Lymphangitis/etiology , Mycoses/diagnosis , Virus Diseases/diagnosis , Bacterial Infections/complications , Bites and Stings/complications , Diagnosis, Differential , Health Knowledge, Attitudes, Practice , Humans , Iatrogenic Disease , Mycoses/complications , Virus Diseases/complications
10.
Lasers Surg Med ; 48(2): 95-115, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26414762

ABSTRACT

BACKGROUND AND OBJECTIVE: The utilization of lasers in dermatology has greatly expanded in recent decades. Acne scarring is a common indication in which lasers play an important therapeutic role. STUDY DESIGN/MATERIALS AND METHODS: Available lasers include traditional ablative lasers, such as carbon dioxide and erbium lasers, traditional non-ablative lasers, such as neodymium, diode, alexandrite, pulsed dye lasers and intense pulse light, as well as both ablative, and non-ablative fractional laser systems. CONCLUSION: We sought to provide a framework for understanding the various types of lasers available to treat acne scars and review the primary literature pertaining to the efficacy, safety, and advantages of each laser discussed.


Subject(s)
Acne Vulgaris/complications , Cicatrix/surgery , Dermatologic Surgical Procedures , Laser Therapy , Dermatologic Surgical Procedures/instrumentation , Dermatologic Surgical Procedures/methods , Humans , Laser Therapy/instrumentation , Laser Therapy/methods
11.
JAMA Dermatol ; 152(1): 73-9, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26421371

ABSTRACT

IMPORTANCE: Psoriasis is a risk factor for depression. Depression may also trigger or exacerbate psoriasis. The relationship between psoriasis and depression, however, remains to be fully explored. OBJECTIVE: To investigate the association between psoriasis and major depression in the US population. DESIGN, SETTING, AND PARTICIPANTS: Population-based study using participants in the National Health and Nutrition Examination Survey from 2009 through 2012. MAIN OUTCOMES AND MEASURES: Diagnosis of major depression based on the Patient Health Questionnaire-9. RESULTS: We identified 351 (2.8%) cases of psoriasis and 968 (7.8%) cases of major depression among 12,382 US citizens included in our study. Fifty-eight (16.5%) patients with psoriasis met criteria for a diagnosis of major depression. The mean (SD) Patient Health Questionnaire-9 score was significantly higher among patients with a history of psoriasis than those without psoriasis (4.54 [5.7] vs 3.22 [4.3], P < .001). Psoriasis was significantly associated with major depression, even after adjustment for sex, age, race, body mass index, physical activity, smoking history, alcohol use, history of myocardial infarction (MI), history of stroke, and history of diabetes mellitus (OR, 2.09 [95% CI, 1.41-3.11], P < .001). Interaction term analyses involving patients with a history of both psoriasis and a cardiovascular event, specifically MI or stroke, did not reveal a synergistically increased risk of major depression (psoriasis and MI: OR, 1.09 [95% CI, 0.28-3.60], P = .91; psoriasis and stroke: OR, 0.67 [95% CI, 0.12-3.66], P = .63). In adjusted multivariable models, the risk of major depression was not significantly different between patients with limited vs extensive psoriasis (OR, 0.66 [95% CI, 0.18-2.44], P = .53). CONCLUSIONS AND RELEVANCE: Self-reported history of psoriasis was independently associated with major depression as assessed by a validated screening tool, even when controlling for comorbidities. History of cardiovascular event did not modify the risk of major depression for patients with psoriasis. The severity of psoriasis was unrelated to the risk of major depression. Therefore, all patients with psoriasis, regardless of severity, may be at risk for major depression.


Subject(s)
Cardiovascular Diseases/epidemiology , Depressive Disorder, Major/epidemiology , Psoriasis/epidemiology , Adult , Aged , Depressive Disorder, Major/etiology , Female , Humans , Male , Middle Aged , Nutrition Surveys , Psoriasis/complications , Psoriasis/pathology , Risk Factors , Severity of Illness Index , United States/epidemiology
12.
Pediatr Dermatol ; 33(1): 44-8, 2016.
Article in English | MEDLINE | ID: mdl-26573093

ABSTRACT

BACKGROUND: Previous studies have characterized differences in vitiligo associated with halo nevi, but the features of vitiligo presenting with halo nevus in children have yet to be fully described. AIMS: We sought to provide an epidemiologic and clinical comparison of cases of childhood vitiligo presenting with or without associated halo nevi. MATERIALS AND METHODS: This was a retrospective chart review of children diagnosed with vitiligo in an academic pediatric dermatology practice from January 1990 to November 2014. The characteristics of children with vitiligo with or without associated halo nevi were compared. RESULTS: Halo nevi were identified in 55 (26%) of 208 children with vitiligo. Patients with halo nevi were significantly more likely to be male and develop vitiligo at a later age. Children with vitiligo associated with halo nevi were more likely to present with generalized vitiligo, defined according to the presence of bilateral macules. DISCUSSION: There was no significant association between groups in the percentage of body surface area with vitiligo or family history of vitiligo or autoimmune diseases. Patients with halo nevi were no more likely to develop new areas of vitiligo during the follow-up period, but there was a nonsignificant trend toward a higher rate of repigmentation in vitiligo associated with halo nevus. CONCLUSION: Halo nevi are a common finding in children with vitiligo. The presence of a halo nevus in a child with vitiligo is associated with generalized vitiligo. The presence of a halo nevus does not significantly alter the risk of disease progression and rate of treatment.


Subject(s)
Nevus, Halo/diagnosis , Vitiligo/diagnosis , Adolescent , Child , Child, Preschool , Disease Progression , Female , Humans , Infant , Male , Retrospective Studies
13.
J Am Acad Dermatol ; 74(2): 348-55, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26549251

ABSTRACT

In ethnic skin, traditional skin resurfacing procedures such as dermabrasion, chemical peels, and laser therapy can be effective but can also be associated with prolonged recovery and risk of complications. These complications can include a higher risk of dyspigmentation and scarring, and unsatisfactory clinical outcomes. Microneedling is an evolving treatment technique for an expanding number of dermatologic conditions. Microneedling may offer a more advantageous safety profile, particularly in the skin-of-color population (Fitzpatrick skin types IV-VI), compared with more conventional resurfacing modalities. Thus far, it has been shown to be effective for a number of dermatologic conditions in this population, including scarring, melasma, melanosis, skin rejuvenation, acne vulgaris, and primary hyperhidrosis. This article aims to provide a comprehensive review of the literature regarding the efficacy and safety of microneedling in skin of color.


Subject(s)
Cicatrix/therapy , Cosmetic Techniques/instrumentation , Needles , Skin Pigmentation , Acne Vulgaris/complications , Acne Vulgaris/therapy , Cicatrix/etiology , Cosmetic Techniques/adverse effects , Humans , Hyperhidrosis/therapy , Melanosis/therapy , Rejuvenation
14.
Am J Clin Dermatol ; 16(6): 463-74, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26329814

ABSTRACT

Vitiligo is a common, acquired disorder of skin pigmentation that can significantly impact quality of life. It often represents a therapeutic challenge, which has resulted in interest in alternative treatments such as herbal and vitamin supplements. In this review, we provide an overview of the most commonly studied complementary agents, describe proposed mechanisms of action, identify potential adverse effects, and discuss the primary evidence supporting their use. Our discussion focuses on L-phenylalanine, Polypodium leucotomos, khellin, Ginkgo biloba, and vitamins and minerals, including vitamins B12, C, and E, folic acid, and zinc used as monotherapy or in combination with other treatments for the management of vitiligo.


Subject(s)
Complementary Therapies/methods , Dietary Supplements , Ginkgo biloba , Vitiligo/diagnosis , Vitiligo/drug therapy , Administration, Oral , Female , Folic Acid/therapeutic use , Humans , Male , Phenylalanine/therapeutic use , Phytotherapy/methods , Prognosis , Prospective Studies , Randomized Controlled Trials as Topic , Retrospective Studies , Risk Assessment , Treatment Outcome , Ultraviolet Therapy/methods , Vitamin B 12/therapeutic use
15.
J Am Acad Dermatol ; 73(3): 467-70, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26118892

ABSTRACT

OBJECTIVES: Vitiligo commonly presents in children, with half of all cases developing before 20 years of age. Although studies have characterized differences between pediatric and adult vitiligo, little is known about vitiligo presenting in early childhood. The purpose of this study was to compare clinical features of early-onset (<3 years old) and later-onset (3-18 years old) childhood vitiligo. METHODS: This retrospective case series examined patients given a diagnosis of vitiligo in a pediatric dermatology practice at an academic medical center from 1990 to 2014. Characteristics of the early- and later-onset groups were compared by χ(2) and t test for categorical and continuous variables, respectively. RESULTS: Of the 208 children in the study, 31 had early-onset and 177 had later-onset disease. Early-onset vitiligo was associated with higher percentages of body surface area involvement and increased rates of disease progression during an average 1.9 years of follow-up. There were no significant differences between the 2 groups in repigmentation, vitiligo type, halo nevi, gender ratio, or personal and family history of autoimmune diseases. LIMITATIONS: This was a retrospective, single-institution study. CONCLUSION: Patients given a diagnosis of vitiligo at younger ages tend to have more extensive and progressive disease.


Subject(s)
Disease Progression , Nevus, Halo/epidemiology , Vitiligo/diagnosis , Vitiligo/epidemiology , Adolescent , Age Distribution , Age of Onset , Child , Child, Preschool , Cohort Studies , Female , Humans , Male , Nevus, Halo/diagnosis , Prognosis , Retrospective Studies , Risk Assessment , Severity of Illness Index , Sex Distribution
16.
Trends Hear ; 182014 Jul 29.
Article in English | MEDLINE | ID: mdl-25080364

ABSTRACT

A number of viral infections can cause hearing loss. Hearing loss induced by these viruses can be congenital or acquired, unilateral or bilateral. Certain viral infections can directly damage inner ear structures, others can induce inflammatory responses which then cause this damage, and still others can increase susceptibility or bacterial or fungal infection, leading to hearing loss. Typically, virus-induced hearing loss is sensorineural, although conductive and mixed hearing losses can be seen following infection with certain viruses. Occasionally, recovery of hearing after these infections can occur spontaneously. Most importantly, some of these viral infections can be prevented or treated. For many of these viruses, guidelines for their treatment or prevention have recently been revised. In this review, we outline many of the viruses that cause hearing loss, their epidemiology, course, prevention, and treatment.


Subject(s)
Hearing Loss/virology , Virus Diseases/virology , Hearing , Hearing Loss/diagnosis , Hearing Loss/physiopathology , Hearing Loss/prevention & control , Hearing Loss/therapy , Humans , Recovery of Function , Risk Factors , Treatment Outcome , Virus Diseases/complications , Virus Diseases/diagnosis , Virus Diseases/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...